Cancer accounts for nearly 1 out of every 4 deaths in the United States, and because conventional treatments are limited by morbidity and off-target toxicities, improvements in cancer management are needed. This thesis further develops nanoparticle-assisted photothermal therapy (NAPT) as a viable treatment option for cancer patients. NAPT enables localized ablation of disease because heat generation only occurs where tissue permissive near-infrared (NIR) light and absorbing nanoparticles are combined, leaving surrounding normal tissue unharmed. Two principle approaches were investigated to improve the specificity of this technique: multimodal imaging and molecular targeting. Multimodal imaging affords the ability to guide NIR laser application for site-specific NAPT and more holistic characterization of disease by combining the advantages of several diagnostic technologies. Towards the goal of image-guided NAPT, gadolinium-conjugated gold-silica nanoshells were engineered and demonstrated to enhance imaging contrast across a range of diagnostic modes, including T1-weighted magnetic resonance imaging, X-Ray, optical coherence tomography, reflective confocal microscopy, and two-photon luminescence in vitro as well as within an animal tumor model. Additionally, the nanoparticle conjugates were shown to effectively convert NIR light to heat for applications in photothermal therapy. Therefore, the broad utility of gadolinium-nanoshells for anatomic localization of tissue lesions, molecular characterization of malignancy, and mediators of ablation was established. Molecular targeting strategies may also improve NAPT by promoting nanoparticle uptake and retention within tumors and enhancing specificity when malignant and normal tissue interdigitate. Here, ephrinA1 protein ligands were conjugated to nanoshell surfaces for particle homing to overexpressed EphA2 receptors on prostate cancer cells. In vitro, successful targeting and subsequent photothermal ablation of prostate cancer cells was achieved with negligible nanoshell binding to normal cells. In vivo however, ephrinA1-nanoshells did not promote enhanced therapeutic outcomes in mice bearing subcutaneous prostate cancer tumors treated with NAPT compared to nontargeted particles. Nonetheless, both treatment groups demonstrated effective ablation of prostate tumors, as evidenced by tumor tissue regression. Further investigation is warranted to overcome probable protein immunogenicity that offsets ephrinA1 targeting in vivo. With future study, photothermal therapy with multimodal gadolinium-conjugated and molecularly targeted nanoshells may offer a viable treatment option for cancer patients in the clinic.

Gold nanoparticles exhibit an array of properties, both intrinsic (chemical) and extrinsic (photothermal), that can be exploited for their use in cancer therapeutics. Owing to their size and ease with which they can be functionalized with various ligands, gold nanoparticles represent a class of highly functional biomedically relevant nanostructures. Here, we explore the use of gold nanoparticles as intrinsic (chemical) antineoplastic agents, with their ability to cause DNA damage and cytokinesis arrest, to induce apoptosis in a metallic composition-dependent manner, as well as their ability to enhance sensitivity to chemotherapy by regulation of the cell cycle. The extrinsic (photothermal) properties of gold nanoparticles are also examined, in detail, through both theoretical and experimental assessment, for their use as photothermal contrast agents in vitro. Based on this assessment, the gold nanoparticles are tested in the plasmonic photothermal therapy of head and neck cancer in a mouse model.

Cancer is one of the most notorious diseases affecting the human population today with very few effective treatments. Due to the disparate nature of cancers, it is difficult to obtain a treatment that can cure cancer. Thus, there is a large influx of research towards cancer therapies, leading to one of the discovery that cancer cells (tumors) have a low thermotolerance in comparison to normal cells. If the temperature of the cancer cells is increased into the hyperthermia range (~45°C) thermal damage occurs, causing cell death by protein denaturation and membrane disruption. A recent development in this field has been in the photothermal treatment of tumors, which is starting to utilize plasmonic particles to enhance the specificity of the treatment. The plasmonic nanoparticles, specifically gold, can reach the tumor site using passive targeting and when irradiated with a tuned laser will emit heat localized to a small region around the nanoparticle killing the surrounding cancer cells. This process has been shown to reduce tumor size in vivo with gold nanoshells and gold nanorods. However, it has not been shown which particle is better at delivering the heat to the tumor site. Therefore in this study, it will be shown which particle generates the most heat. Solutions of tissue simulating phantom and different concentrations of nanoparticles were irradiated with a laser to measure the increase in temperature. Additionally, simulations were performed using Mie Theory for nanoshells and the Discrete Dipole Approximation for nanorods. Based on the physical parameters of the nanoshells and nanorods used in this experiment, the adjusted absorption cross-section was determined. It was found that nanoshells generated the most amount of heat on a per particle basis, and that it was necessary to have a nanorod concentration of 5.5 times the concentration of nanoshells to generate the same amount of heat as nanoshells. These results were confirmed using Monte Carlo and Finite Difference Modeling of the nanoparticle heating experiments. However, the choice of nanoparticle still depends on the application and the targeting efficiency in vivo. / text

Gold nanoparticles (AuNPs) with their unique sizes, shapes, and properties have generated much enthusiasm over the last two decades, and have been explored for many potential applications. The successful application of AuNPs depends critically on the ability to modify and functionalize their surface to provide stability, compatibility, and special chemical functionality. This dissertation is aimed at exploring the chemical synthesis and surface modification of AuNPs with the effort to (1) control the number of functional groups on the particle surface, and to (2) increase the colloidal stability at the physiological conditions. To control the functionality on the particle surface, a solid phase place exchange reaction strategy was developed to synthesize the 2 nm AuNPs with a single carboxylic acid group attached on the particle surface. Such monofunctional AuNPs can be treated and used as molecular nanobuilding blocks to form more complex nanomaterials with controllable structures. A "necklace"-like AuNP/polymer assembly was obtained by conjugating covalently the monofunctional AuNPs with polylysine template, and exhibited an enhanced optical limiting property due to strong electromagnetic interaction between the nanoparticles in close proximity. To improve the colloidal stability in the psychological condition, biocompatible polymers, polyacrylic acid (PAA), and polyethylene glycol (PEG) were used to surface modify the 30 nm citrate-stabilized AuNPs. These polymer-modified AuNPs are able to disperse individually in the high ionic strength solution, and offer as the promising optical probes for bioassay applications. The Prostate specific antigen (PSA) and target DNA can be detected in the low pM range by taking advantages of the large scattering cross section of AuNPs and the high sensitivity of dynamic light scattering (DLS) measurement. In addition to the large scattering cross section, AuNPs can absorb strongly the photon energy at the surface plasmon resonance wavelength and then transform efficiently to the heat energy. The efficient photon-thermal energy conversion property of AuNPs has been used to thermal ablate the Aβ peptide aggregates under laser irradiation toward Alzheimer's disease therapy.

Plasmonic photothermal therapy (PPTT) has a rising promise for treating different cancer cells such as lymphoma or stomach cancer. Technique development of PPTT using metallic nanoparticles is developed upon a modification of the irradiation therapy using two major changes: using a less harmful visible amber light (excluding blue light) and using gold-loaded biocompatible nanoparticles. Acrylate nanoparticles were loaded with desired types of gold nanoparticles at different sizes. The gold-loaded gold nanoparticles were conjugated to cancer cells. By selectively delivering the gold nanoparticles into cancer cells, irradiating a harmless amber visible light will achieve thermal ablation of the cancer cells. Based on imaging spectroscopy, flow cytometry, and cell viability assays, results showed reduction of gold-loaded viable cancer cells upon irradiating with amber visible light, no change in the number of cancer cells with irradiating with light only. On the other hand, DNA intercalation of a trinuclear gold(I), [Au(3-CH3,5-COOH)Pz]3 (Au3) is contrasted with the standard organic intercalators ethidium and ellipticine, as investigated computationally. Frontier molecular orbital energies of intercalators and DNA base pairs were determined and found that all intercalators are good electron acceptors with Au3 being the best electron acceptor having the lowest LUMO. DNA base pairs are better electron donors having the lowest HOMO values, and from the intercalators and base pairs' HOMO/LUMO energies, it is evident the intercalators will overlap with the HOMO of DNA stabilizing the intercalators. Interaction energies (kcal/mol) were obtained as a function of distance, r (angstroms). Results show that the theoretical treatment SDD-WB97XD outperforms SDD-LSDA in both adenine-thymine (AT) systems with ethidium and Au3 intercalators. In both guanine-cytosine (GC) and AT pairs, the Au3 has the lowest interaction energies among these common intercalators, suggesting a potential intercalating drug. Experimental DNA intercalation studies were attempted and methods of finding intercalation binding constants were established, showing gold complexes have better binding constants to DNA than common intercalators to support the computational results.

Multifunctional plasmonic nanoparticles have shown extraordinary potential for near infrared photothermal and triggered-therapeutic release treatments of solid tumors. However, the accumulation rate of the nanoparticles in the target tissue, which depends on their capacity to escape the immune system, and the ability to efficiently and accurately track these particles in vivo are still limited. To address these challenges, we have created two different systems. The first one is a multifunctional nanocarrier in which PEG-coated gold nanorods were grouped into natural cell membrane vesicles from lung cancer cell membranes (A549) and loaded with β-lap (CM-β-lap-PEG-AuNRs). Our goal was to develop specific multifunctional systems for cancer treatment by using the antigens and the unique properties of the cancer cell membrane combined with photothermal properties of AuNRs and anticancer activity of β-lap. The results confirmed the assembly of PEG-AuNRs inside the vesicles and the irradiation with NIR laser led to disruption of the vesicles and release of the PEG-AuNRs and β-Lap. In vitro studies revealed an enhanced and synergic cytotoxicity against A549 cancer cells, which can be attributed to the specific cytotoxicity of β-Lap combined with heat generated by laser irradiation of the AuNRs. No cytotoxicity was observed in absence of laser irradiation. In the second system, MRI-active Au nanomatryoshkas were developed. These are Au core-silica layer-Au shell nanoparticles, where Gd(III) ions are encapsulated within the silica layer between the inner core and outer Au layer of the nanoparticle (Gd-NM). This theranostic nanoparticle retains its strong near infrared optical absorption properties, essential for in vivo photothermal cancer therapy, while simultaneously providing increased T1 contrast in MR imaging by concentrating Gd(III) within the nanoparticle. Measurements of Gd-NM revealed a substantially enhanced T1 relaxivity (r1 ~ 17 mM-1 s-1) even at 4.7 T, surpassing conventional Gd(III)-DOTA chelating agents (r1 ~ 4 mM-1 s-1) currently in clinical use. The observed relaxivities are consistent with Solomon-Bloembergen-Morgan (SBM) theory, describing the longer-range interactions between the Gd(III) and protons outside the nanoparticle. These novel multifunctional systems open the door for the development of more efficient nanoplatforms for diagnosis and treatment of cancer. / Nanopartículas plasmônicas multifuncionais têm revelado elevado potencial para fototermia na região (NIR) do infravermelho e liberação controlada de fármacos para o tratamento de tumores sólidos. No entanto, a taxa de acumulação das nanoparticulas no tecido alvo, que depende da capacidade delas de escapar do sistema imunológico, e a habilidade de rastrear de maneira efetiva essas partículas in vivo ainda são limitadas. Para superar essas barreiras, dois sistemas diferentes foram desenvolvidos. O primeiro corresponde a um nanocarreador multifunctional, onde nanobastões de ouro funcionalizados com PEG foram agrupados dentro de vesículas de membranas de células naturais originarias de células cancerígenas de pulmão (A549) conjugadas com β-Lap (CM-β-lap-PEG-AuNRs). Nosso principal objetivo foi desenvolver um sistema multifuncional especifico para tratamento de câncer utilizando os antígenos e propriedades únicas da membrana das células cancerígenas combinados com as propriedades fototérmicas dos AuNRs e a atividade anticancerígena da β-Lap. Os resultados confirmaram o agrupamento dos PEG-AuNRs dentro das CM e irradiação com o laser no NIR levou ao rompimento das vesículas e liberação dos AuNRs e β-Lap. Estudos in vitro revelaram uma elevada e sinérgica citotoxicidade contra células A549, que pode ser atribuída a combinação da especifica toxicidade da β-Lap com o calor gerado pelos AuNRs por meio da irradiação com laser. Nenhuma citotoxicidade significativa foi observada na ausência de irradiação com laser. No segundo sistema, nanomatryoshkas de Au ativas em MRI foram desenvolvidas. Elas consistem em um núcleo de Au, uma camada intersticial de sílica, onde os íons de Gd(III) são encapsulados, e uma camada externa de Au (Gd-NM). Esta nanopartícula teranóstica mantém as propriedades de elevada absorção óptica no NIR, enquanto simultaneamente fornece um elevado contraste T1 em imagem por ressonância magnética por meio da concentração dos íons de Gd(III) dentro da nanoparticula. Medidas de Gd-NM revelaram uma relaxividade elevada (r1 ~ 17 mM-1 s-1 ) a 4,7 T, superando os convencionais agentes quelantes de Gd(III)-DOTA (r1 ~ 4 mM-1 s-1) utilizados clinicamente. As relaxividades observadas são consistentes com a teoria Solomon-Bloembergen-Morgan (SBM), descrevendo as interações de longo alcance entre Gd(III) e prótons de H fora da partícula. Os novos sistemas multifuncionais desenvolvidos abrem oportunidades para o desenvolvimento de nanoplataformas mais eficientes para o diagnóstico e tratamento de câncer.

Gold nanoparticles strongly absorb and scatter visible and near infrared light because of the strongly enhanced electric fields at the surface. This provides the potential of designing novel optically active reagents for simultaneous molecular imaging and photothermal cancer therapy. In this thesis, gold nanospheres and nanorods conjugated with anti-epidermal growth factor receptor (anti-EGFR) antibodies that specifically target EGFR on the cell surface are shown to be used for dual diagnostics and therapy. Using micro-absorption spectroscopy and light scattering imaging, cancerous (HOC 313 and HSC 3) and noncancerous cells (HaCat) can be differentiated due to the overexpression of EGFR on the surface of cancer cells. By irradiating the cells with a CW laser, selective photothermal cancer therapy is realized in visible region by using gold nanospheres and in near infrared region by using gold nanorods. The use of nanorods allow for in vivo therapy due to the fact that their absorption is in the near infrared region at which the laser light meets less interference from the tissue absorption. In addition, the catalytic effect of gold nanoparticles on the oxidization of NADH to NAD+ is investigated. The addition of gold nanoparticles is found to quench the NADH fluorescence intensities but has no effect on the fluorescence lifetime. This suggests that the fluorescence quenching is not due to coupling with the excited state, but due to changing the ground state of NADH. The intensity of the 340 nm absorption band of NADH is found to decrease while that of the 260 nm band of NAD+ is found to increase as the concentration of gold nanoparticles increase. This conversion reaction is further supported by nuclear magnetic resonance and mass spectroscopy. The linear relationship between the initial reaction rate of NADH and the concentration of gold nanoparticles strongly supports that NADH is surface catalyzed by the gold nanoparticles. The catalytic property of this important reaction might have important future applications in biological and medical fields.

Gold nanoparticles, a class of plasmonic nanoparticle, have increasingly been explored as an imaging and therapeutic agent to treat cancer due to their characteristic surface plasmon resonance phenomenon and penchant for tumor accumulation. Photothermal therapy has been shown as a promising cancer treatment by delivering heat specifically to the tumor site via gold nanoparticles. In this study, we demonstrate that gold nanorod (GNR)-mediated photothermal therapy can be more effective through the understanding of cell death mechanisms. By targeting GNRs to various cellular localizations, we explored the association of GNR localization with cell death pathway response to photothermal therapy. Furthermore, we compared the 2D monolayer experiments with 3D in vitro tumor models, multicellular tumor spheroids (MCTS), to mimic the structure of in vivo tumors. With MCTS, we evaluated the cell death response with GNRs distributed only on the periphery, as seen in typical in vivo studies, and distributed evenly throughout the tumor. We demonstrated that GNR localization influences the cell death response to photothermal therapy by showing the power threshold necessary to induce significant apoptotic and necrotic increases was lower for internalized GNRs than membrane-bound GNRs. Furthermore, apoptosis was found to increase with increasing laser power until the necrotic threshold and decreased above it, as necrosis became the dominant cell death pathway response. A similar trend was revealed with the 3D MCTS; however, the overall cell death percentages were lower, most likely due to the upregulated cell repair response and varied GNR distributions due to the presence of cell-cell and cell-matrix interactions. Furthermore, the uniformly distributed GNRs induced more apoptosis and necrosis than GNRs located in the MCTS periphery. In conclusion, we quantitatively analyzed the cell death pathway response to GNR-mediated photothermal therapy to establish that it has some dependence on GNR localization and distribution to gain a more thorough understanding of this response for photothermal therapy optimization. / text

The persistence of high global mortality rates directly attributable to cardiovascular disease drives ongoing research into novel approaches for improved diagnosis and treatment of its primary underlying cause, atherosclerosis. Combined intravascular ultrasound and photoacoustic (IVUS/IVPA) imaging is one such modality, actively being developed as a tool for improved characterization of high-risk atherosclerotic plaques. The pathophysiology associated with progression and destabilization of atherosclerotic plaques leads to characteristic changes in arterial morphology and composition. IVUS/IVPA imaging seeks to expand upon the ability of clinically utilized intravascular ultrasound (IVUS) imaging to assess vessel anatomy by adding improved sensitivity to image the underlying cellular and molecular composition through intravascular photoacoustic (IVPA) imaging of either endogenous chromophores (e.g. lipid) or exogenously delivered contrast agents. This dissertation focuses on the expansion of IVUS/IVPA imaging using exogenous contrast agents to enable the detection and subsequent optically-triggered therapy of atherosclerotic plaques. The passive extravasation and aggregation of systemically injected plasmonic gold nanorods absorbing within the near infrared tissue optical window within plaques of atherosclerotic rabbit models is first demonstrated, along with the ability to localize the contrast agents using ex vivo IVUS/IVPA imaging. The motivation for nanoparticle labeling of atherosclerosis is then expanded from that of purely image contrast agents to vehicles for image-guided, dual-modality phototherapy. The integrated IVUS/IVPA imaging catheter is utilized for photothermal delivery with simultaneous IVPA temperature monitoring using the high optical absorption of gold nanorod contrast agents to enable localized heating. Subsequently, the potential role for IVUS/IVPA-guided phototherapy is further expanded through the characterization and in vitro assessment of novel multifunctional theranostic nanoparticles comprised of a gold nanorod core with a degradable, photosensitizer-doped silica shell. Together, the results presented within this dissertation provide a framework for ongoing research into the expansion of IVUS/IVPA imaging as a platform for complimentary diagnosis and local treatment of atherosclerotic plaques using multifunctional theranostic nanoparticle contrast agents. / text

Multifunctional plasmonic nanoparticles have shown extraordinary potential for near infrared photothermal and triggered-therapeutic release treatments of solid tumors. However, the accumulation rate of the nanoparticles in the target tissue, which depends on their capacity to escape the immune system, and the ability to efficiently and accurately track these particles in vivo are still limited. To address these challenges, we have created two different systems. The first one is a multifunctional nanocarrier in which PEG-coated gold nanorods were grouped into natural cell membrane vesicles from lung cancer cell membranes (A549) and loaded with β-lap (CM-β-lap-PEG-AuNRs). Our goal was to develop specific multifunctional systems for cancer treatment by using the antigens and the unique properties of the cancer cell membrane combined with photothermal properties of AuNRs and anticancer activity of β-lap. The results confirmed the assembly of PEG-AuNRs inside the vesicles and the irradiation with NIR laser led to disruption of the vesicles and release of the PEG-AuNRs and β-Lap. In vitro studies revealed an enhanced and synergic cytotoxicity against A549 cancer cells, which can be attributed to the specific cytotoxicity of β-Lap combined with heat generated by laser irradiation of the AuNRs. No cytotoxicity was observed in absence of laser irradiation. In the second system, MRI-active Au nanomatryoshkas were developed. These are Au core-silica layer-Au shell nanoparticles, where Gd(III) ions are encapsulated within the silica layer between the inner core and outer Au layer of the nanoparticle (Gd-NM). This theranostic nanoparticle retains its strong near infrared optical absorption properties, essential for in vivo photothermal cancer therapy, while simultaneously providing increased T1 contrast in MR imaging by concentrating Gd(III) within the nanoparticle. Measurements of Gd-NM revealed a substantially enhanced T1 relaxivity (r1 ~ 17 mM-1 s-1) even at 4.7 T, surpassing conventional Gd(III)-DOTA chelating agents (r1 ~ 4 mM-1 s-1) currently in clinical use. The observed relaxivities are consistent with Solomon-Bloembergen-Morgan (SBM) theory, describing the longer-range interactions between the Gd(III) and protons outside the nanoparticle. These novel multifunctional systems open the door for the development of more efficient nanoplatforms for diagnosis and treatment of cancer. / Nanopartículas plasmônicas multifuncionais têm revelado elevado potencial para fototermia na região (NIR) do infravermelho e liberação controlada de fármacos para o tratamento de tumores sólidos. No entanto, a taxa de acumulação das nanoparticulas no tecido alvo, que depende da capacidade delas de escapar do sistema imunológico, e a habilidade de rastrear de maneira efetiva essas partículas in vivo ainda são limitadas. Para superar essas barreiras, dois sistemas diferentes foram desenvolvidos. O primeiro corresponde a um nanocarreador multifunctional, onde nanobastões de ouro funcionalizados com PEG foram agrupados dentro de vesículas de membranas de células naturais originarias de células cancerígenas de pulmão (A549) conjugadas com β-Lap (CM-β-lap-PEG-AuNRs). Nosso principal objetivo foi desenvolver um sistema multifuncional especifico para tratamento de câncer utilizando os antígenos e propriedades únicas da membrana das células cancerígenas combinados com as propriedades fototérmicas dos AuNRs e a atividade anticancerígena da β-Lap. Os resultados confirmaram o agrupamento dos PEG-AuNRs dentro das CM e irradiação com o laser no NIR levou ao rompimento das vesículas e liberação dos AuNRs e β-Lap. Estudos in vitro revelaram uma elevada e sinérgica citotoxicidade contra células A549, que pode ser atribuída a combinação da especifica toxicidade da β-Lap com o calor gerado pelos AuNRs por meio da irradiação com laser. Nenhuma citotoxicidade significativa foi observada na ausência de irradiação com laser. No segundo sistema, nanomatryoshkas de Au ativas em MRI foram desenvolvidas. Elas consistem em um núcleo de Au, uma camada intersticial de sílica, onde os íons de Gd(III) são encapsulados, e uma camada externa de Au (Gd-NM). Esta nanopartícula teranóstica mantém as propriedades de elevada absorção óptica no NIR, enquanto simultaneamente fornece um elevado contraste T1 em imagem por ressonância magnética por meio da concentração dos íons de Gd(III) dentro da nanoparticula. Medidas de Gd-NM revelaram uma relaxividade elevada (r1 ~ 17 mM-1 s-1 ) a 4,7 T, superando os convencionais agentes quelantes de Gd(III)-DOTA (r1 ~ 4 mM-1 s-1) utilizados clinicamente. As relaxividades observadas são consistentes com a teoria Solomon-Bloembergen-Morgan (SBM), descrevendo as interações de longo alcance entre Gd(III) e prótons de H fora da partícula. Os novos sistemas multifuncionais desenvolvidos abrem oportunidades para o desenvolvimento de nanoplataformas mais eficientes para o diagnóstico e tratamento de câncer.